Celgene and BMS-backed cancer therapy developer Repare Therapeutics has filed to go public after raising more than $165m in equity financing.

NTT Docomo-backed Wasabi plans to use the proceeds from the $30m round to expand its hot cloud storage service in international markets.

Video messaging platform developer Loom, which counts Slack as an investor, closed a $28.8m round that reportedly doubled its valuation to $350m.

Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, Roche Finance and Ascension Ventures all took part in the cancer data provider's latest round.

Offshore wind technology developer Principle received funding from Tokyo Gas, which joined existing investors including EDP Ventures, Repsol and ASM Industries.

Illumina, General Atlantic and Viking Global have supplied $70m for Ginkgo Bioworks, an MIT spinout that has now raised more than $789m altogether.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Q32 Bio has launched with $46m from investors including University of Colorado to target autoimmune and inflammatory diseases.

Illumina, General Atlantic and Viking Global Investors supplied $70m for Ginkgo Bioworks, a cell programming technology provider that has now raised more than $789m altogether.

Amazon Alexa Fund contributed to the home automation technology producer's series C round through its Alexa Fund, revealing itself as an existing investor in the process.